Normal 0 false false false MicrosoftInternetExplorer4 Threshold Pharmaceuticals Inc. (NASDAQ: THLD) shares rose 4.8% to $5.50 after the firm said it has reached an agreement with a U.S. affiliate of Merck Kgaa to develop a new treatment for cancer patients. Threshold traded in 1.4 million shares. /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}